The US charged a Google software engineer with insider trading after he allegedly made a profit of $1.2 million on Polymarket bets related to which public figures would top Google's rankings for the most searched names in 2025. Michele Spagnuolo, an Italian citizen who lives in Switzerland, "was arrested on Wednesday and brought before a federal judge in New York," the BBC wrote .

Spagnuolo was charged "with commodities fraud, wire fraud, and money laundering arising from his scheme to misappropriate confidential information from his employer and use that information to place a series of profitable Google-related trades on a prediction market platform," the Justice Department announced yesterday.

An unsealed criminal complaint said that Spagnuolo, using the account name “AlphaRaccoon” on Polymarket, made bets on who would be the most-searched people on Google in 2025. "Unlike the counterparties to his trades, Spagnuolo knew the outcome of these wagers before the trading public did because he had accessed Google’s confidential, commercially valuable internal data," the complaint said.

Read full article

Comments

Despite all the graphics capabilities of modern Macs, being a Mac gamer is generally a thankless existence. Every once in a while, though, Mac gamers get a bone thrown to them that is substantial enough that they think, for a brief moment, everything might be OK. One such bone has been thrown to us today— Age of Empires II: Definitive Edition just came out on macOS .

The game is available on Steam (those who own the Windows version on Steam automatically get the Mac version) and is planned for a later Mac App Store release.

Read full article

Comments

It's impossible to totally avoid generative AI when interacting with technology anymore, but Apple has a bit less of it. That's not entirely by choice, though. The iPhone maker has delayed the AI-enhanced Siri multiple times since first promising it in 2024, but a deal with Google will merge the iconic assistant with Gemini later this year. As we approach the Worldwide Developers Conference , Apple has been working to bring big AI smarts to the modest processing environment of a smartphone. Apple fans may not like the outcome, though.

Apple has long crowed about the privacy value of running AI locally , but a new report suggests that despite Apple's best efforts, the iPhone's Gemini makeover will lean heavily on Google and Nvidia in the cloud. The Information reports that Apple's Gemini-infused Siri will run both on-device and in the cloud, an apparent reversal of its privacy-focused preference for local AI.

With every new chip announcement, we hear about how the silicon has been optimized for AI—even Apple does this with its focus on Neural Engine upgrades. You may think from the grandiose language that smartphones are equipped to handle beefy AI models, but that's not necessarily the case . In fact, the GPUs in most phones can process more AI tokens than the AI-focused NPUs. Components like Apple's Neural Engine are designed for contextual, efficient AI processing. Even if phones had faster AI processing, they lack the RAM to keep enormous models in memory.

Read full article

Comments

It was less than two months ago that the third flight of Blue Origin's heavy-lift New Glenn rocket left a customer's payload in an unusable orbit. Investigators have now identified the cause of the failure, and Blue Origin is preparing to launch the next New Glenn mission as soon as next week.

The Federal Aviation Administration and Blue Origin announced the closure of the failure investigation May 22. Yesterday, officials confirmed Blue Origin's next launch will loft a payload of 48 commercial satellites for Amazon's broadband network in low-Earth orbit. This will be the most satellites Amazon has launched on a single rocket, surpassing previous flights on United Launch Alliance's Atlas V, SpaceX's Falcon 9, and Europe's Ariane 6.

Blue Origin and Amazon, each founded by Jeff Bezos, have not officially revealed a target launch date, but public notices of airspace and maritime closures suggest the mission is set to lift off from Cape Canaveral Space Force Station, Florida, as soon as next Thursday, June 4. Blue Origin is expected to roll the New Glenn rocket to its launch pad in the coming days for a test-firing of its seven main engines, fueled by liquified natural gas and liquid oxygen.

Read full article

Comments

Scientists have long known that migrating birds and homing pigeons navigate in part by sensing the Earth's magnetic fields, especially at night or in overcast conditions when visual landmarks or sunshine are in short supply. But exactly where this magneto-sensing occurs in the body—and the mechanism that enables it—remains a matter of intense debate. A new paper published in the journal Science suggests that homing pigeons have iron-rich immune cells in their livers that help them detect magnetic fields and transmit that information to the brain.

There are three primary hypotheses for how birds might sense Earth's geomagnetic field. One is a compass-like mechanism, whereby the Earth exerts a pull on magnetic particles in a bird's upper beak that relays directional information via a large nerve in the cranium. A second is that it happens biologically via cellular ion channels sensitive to voltage, enabling birds to sense changes in the magnetic field. And a third suggests that physical effects on retinal pigments enable birds to detect photons and send signals to the brain, although this mechanism is really only viable in the light.

None fully explain how animals can sense magnetic fields. However, “We had some clues that the liver and spleen have magnetic properties, because they break down red blood cells and so store much iron in the body,” said co-author Clivia Lisowski of the University of Bonn and the University Hospital Bonn. This refers to a 2015 paper suggesting that red pulp macrophages in the spleens of mice and humans are intrinsically superparamagnetic and hence more sensitive to magnetic fields. But it wasn't clear if those properties were involved in any kind of magnetoreception.

Read full article

Comments

Most of the Steam Deck imitators on the market right now use AMD silicon, specifically the Ryzen Z-series chips. These are the same chips AMD makes for regular laptops, but with different power settings better suited to a compact handheld system. There are handhelds based on Intel silicon ( MSI’s Claw is the main one), but Intel hasn’t yet tried making silicon marketed specifically for that purpose.

Today, the company is throwing its hat in the ring with two Intel Arc G-series processors, which will allow gaming handhelds to leverage the company's genuinely quite good Arc B-series integrated GPUs. Intel says that several Arc G-series handhelds will arrive "starting in June 2026, with broader availability throughout the year." These systems will include a new MSI Claw model, a Predator Atlas 8 from Acer, and a device from OneXPlayer .

Intel normally uses its "Arc" branding for integrated and dedicated GPUs, but in this case, the "Arc" brand encompasses the entire chip, including the CPU, GPU, NPU, and other components.

Read full article

Comments

A few days after President Donald Trump abruptly canceled a plan that would have given the federal government power to vet frontier AI models over fears that it might hobble innovation, Illinois lawmakers passed the nation's strongest AI safety law.

On Wednesday, the Illinois legislature passed SB 315 . If Illinois Governor J.B. Pritzker signs the bill into law, the largest AI firms would be required to submit public safety plans and annual reports summarizing the results of independent, third-party safety testing of their frontier models. They would also have to report any critical safety incidents to the state within 72 hours—or within 24 hours if there's potentially "an imminent risk of death or serious physical harm." And their employees will have a clear avenue for reporting emerging safety risks that companies may be tempted to downplay, with protections provided by the state's whistleblower laws.

On X, Pritzker confirmed his intent to sign, proclaiming that "Illinois is leading the nation in holding Big Tech accountable."

Read full article

Comments

Well, that was fast. Less than 24 hours after Valve announced renewed availability of the Steam Deck OLED (at a massively increased MSRP), the handheld is once again listed as "out of stock" in the US and Canada. Spot checks of other regional Steam stores on Thursday morning showed the hardware as still available across Europe and Australia for the time being, as well as in Asian countries through Valve's sales partner Komodo.

While it's hard to know from the outside just how many Steam Deck units sold at the new inflated price, those sales were enough to once again boost the hardware to the top of Steam's Top Sellers list . That list is based on total revenue over the last 24 hours , though, so the $789 Steam Deck could easily have sold many fewer distinct copies than the highest-ranked software on the current list, the $70 007 First Light .

Valve's Steam Deck store page notes that the handheld "may be out-of-stock intermittently in some regions due to memory and storage shortages." But that warning first appeared on the store site back in February , and stock-tracking websites show there have only been exceedingly brief availability windows for Steam Deck purchases between then and now.

Read full article

Comments

An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a positive start in an early clinical trial.

Researchers running a Phase I safety trial for the drug, dubbed VERVE-102, published interim results from just 35 patients this week in the New England Journal of Medicine . Though the numbers are small and the analysis is preliminary, VERVE-102 appeared safe, with no serious adverse events reported from the treatment, even at the largest doses. The most significant finding was a temporary, mild increase of a liver enzyme that suggested minor injury in the liver, where the drug works.

The small amount of data also hints that the drug is effective. The subgroup of participants who received the largest dose have seen their bad cholesterol—that is, their low-density lipoprotein or LDL—drop 62 percent, to a mean of 78 mg per deciliter. For people with high cholesterol—like the participants in the trial—a reduction of this magnitude could cut the risk of cardiovascular disease from plaque buildup in arteries by an estimated 50 percent if it's sustained for over 20 years. The trial only has up to 18 months of follow-up data so far, but from that, the positive effects of VERVE-102 seem to be holding up. The LDL reductions have been sustained in all the subgroups.

Read full article

Comments